Table 3 Predictors of biochemical recurrence-free survival in patients with Nadir PSA ≥ 0.06 ng/mL

Age (≤ 70 versus > 70 years)

1.248 (0.443–3.514)

0.675

1.178 (0.209–6.622)

0.853

T stage (T1-2 versus T3–4)

1.342 (0.461–3.908)

0.590

2.848 (0.515–15.747)

0.230

Gleason Score (≤ 7 versus 8–10)

2.118 (0.595–7.537)

0.247

3.018 (0.696–13.090)

0.140

PSA at presentation (≤ 20 versus > 20 ng/mL)

0.939 (0.310–2.840)

0.911

1.543 (0.412–5.787)

0.520

Total ADT duration*

0.319 (0.110–0.921)

0.035

0.306 (0.099–0.946)

0.040